drugset / Trial / NCT02082756

Effects of Berberine Hydrochloride and Bifidobacterium in Prediabetes Prevention and Treatment

NCT02082756

Phase 2/3 Withdrawn Xijing Hospital
RandomizedParallel-groupOpen-labelPrevention

Summary

The aim of this study is to assess the beneficial effects of Bifidobacterium and Berberine Hydrochloride on lowering glucose and delaying progress to diabetes in patients with prediabetes and to detect the potential mechanism.

Timeline

Start
2015-11
Primary completion
2018-04
Completion
2018-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Berberine Traditional medicine (herbal / TCM) 0.5 g
Subject Bifidobacterium viable pharmaceutics Other / unclassified

Indications